Skip to main content
. 2023 May 29;14:1199631. doi: 10.3389/fimmu.2023.1199631

Figure 3.

Figure 3

Strategies targeting macrophages combined with PD-1/PD-L1 antibodies. Therapies targeting macrophages include eliminating of TAMs, inhibiting recruitment, and reprogramming TAMs, in addition to the application of some nanomaterials. CSF-1, colony-stimulating factor 1; CSF1R, colony stimulating factor 1 receptor; MDSC, myeloid-derived suppressor cells; CCL2, C-C chemotactic factor ligand 2; CCR2, C-C chemotactic receptor 2; HCQ, hydroxychloroquine. The figure was created with BioRender.com.